DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Ambrose PG, Drusano GL, Craig WA.
In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humans.
Clin Infect Dis 2012;
54 (Suppl. 03) S220-S228
We do not assume any responsibility for the contents of the web pages of other providers.